{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:07:11Z","timestamp":1790136431537,"version":"4.0.1"},"reference-count":60,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Leading Geese plan in Zhejiang Province","award":["2023C03047"],"award-info":[{"award-number":["2023C03047"]}]},{"name":"Leading Geese plan in Zhejiang Province","award":["WKJ-ZJ-2535"],"award-info":[{"award-number":["WKJ-ZJ-2535"]}]},{"name":"Leading Geese plan in Zhejiang Province","award":["WKJ-ZJ-2535"],"award-info":[{"award-number":["WKJ-ZJ-2535"]}]},{"name":"Research Fund of National Health Commission &amp; Zhejiang major Health Science and Technology","award":["2023C03047"],"award-info":[{"award-number":["2023C03047"]}]},{"name":"Research Fund of National Health Commission &amp; Zhejiang major Health Science and Technology","award":["WKJ-ZJ-2535"],"award-info":[{"award-number":["WKJ-ZJ-2535"]}]},{"name":"Research Fund of National Health Commission &amp; Zhejiang major Health Science and Technology","award":["WKJ-ZJ-2535"],"award-info":[{"award-number":["WKJ-ZJ-2535"]}]},{"name":"Zhejiang province Multidisciplinary innovation team of traditional Chinese medicine for diabetes diagnosis and treatment","award":["2023C03047"],"award-info":[{"award-number":["2023C03047"]}]},{"name":"Zhejiang province Multidisciplinary innovation team of traditional Chinese medicine for diabetes diagnosis and treatment","award":["WKJ-ZJ-2535"],"award-info":[{"award-number":["WKJ-ZJ-2535"]}]},{"name":"Zhejiang province Multidisciplinary innovation team of traditional Chinese medicine for diabetes diagnosis and treatment","award":["WKJ-ZJ-2535"],"award-info":[{"award-number":["WKJ-ZJ-2535"]}]},{"name":"Research Fund of National Health Commission &amp; Zhejiang major Health Science and Technology","award":["2023C03047"],"award-info":[{"award-number":["2023C03047"]}]},{"name":"Research Fund of National Health Commission &amp; Zhejiang major Health Science and Technology","award":["WKJ-ZJ-2535"],"award-info":[{"award-number":["WKJ-ZJ-2535"]}]},{"name":"Research Fund of National Health Commission &amp; Zhejiang major Health Science and Technology","award":["WKJ-ZJ-2535"],"award-info":[{"award-number":["WKJ-ZJ-2535"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Obesity-related metabolic diseases include conditions linked to obesity, such as type 2 diabetes, hypertension, steatotic liver disease, and polycystic ovary syndrome. These disorders are primarily caused by insulin resistance, chronic inflammation, and excessive fat accumulation. They represent significant health challenges and often remain asymptomatic during their early stages. Traditional diagnostic tools, including blood glucose, lipid levels, blood pressure, and uric acid measurements, provide valuable insights but fall short of fully capturing the complexity of metabolic dysfunction. Consequently, there is a growing need for noninvasive, easily accessible biomarkers, especially those found in urine, to enable more accurate, sensitive, and patient-friendly diagnostic methods. Urine, with its diverse range of metabolites that reflect the body\u2019s metabolic changes, is an ideal sample for early detection. Recent advancements in urine metabolomics and proteomics have highlighted the potential of urinary biomarkers for diagnosing obesity-related metabolic diseases. Despite challenges such as the need for standardized detection techniques and clinical validation, the integration of artificial intelligence and multi-omics approaches holds significant promise for enhancing diagnostic accuracy and advancing disease management strategies.<\/jats:p>","DOI":"10.3390\/biom15050633","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:35:13Z","timestamp":1746185713000},"page":"633","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Noninvasive Urinary Biomarkers for Obesity-Related Metabolic Diseases: Diagnostic Applications and Future Directions"],"prefix":"10.3390","volume":"15","author":[{"given":"Shumin","family":"Zhan","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Children\u2019s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310051, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0240-0652","authenticated-orcid":false,"given":"Xuelian","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Children\u2019s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310051, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6405-1251","authenticated-orcid":false,"given":"Junfen","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Children\u2019s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310051, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"ref_1","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2024). Worldwide Trends in Underweight and Obesity from 1990 to 2022: A Pooled Analysis of 3663 Population-Representative Studies with 222 Million Children, Adolescents, and Adults. Lancet, 403, 1027\u20131050."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Okunogbe, A., Nugent, R., Spencer, G., Powis, J., Ralston, J., and Wilding, J. (2022). Economic Impacts of Overweight and Obesity: Current and Future Estimates for 161 Countries. BMJ Glob. Health, 7.","DOI":"10.1136\/bmjgh-2022-009773"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of Type 2 Diabetes\u2014Global Burden of Disease and Forecasted Trends","volume":"10","author":"Khan","year":"2020","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/ajh.2010.172","article-title":"Obesity-Related Hypertension: Epidemiology, Pathophysiology, and Clinical Management","volume":"23","author":"Kotchen","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing Epidemiology, Global Trends and Implications for Outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_6","first-page":"354","article-title":"Direct Medical Costs of Obesity in the United States and the Most Populous States","volume":"27","author":"Cawley","year":"2021","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/CIRCRESAHA.120.315898","article-title":"Metabolomics and Proteomics in Type 2 Diabetes","volume":"126","author":"Chen","year":"2020","journal-title":"Circ. Res."},{"key":"ref_8","first-page":"576","article-title":"Multi-Omics Profiling: The Way towards Precision Medicine in Metabolic Diseases","volume":"13","author":"Hu","year":"2021","journal-title":"J. Mol. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bouatra, S., Aziat, F., Mandal, R., Guo, A.C., Wilson, M.R., Knox, C., Bjorndahl, T.C., Krishnamurthy, R., Saleem, F., and Liu, P. (2013). The Human Urine Metabolome. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073076"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Elliott, P., Posma, J.M., Chan, Q., Garcia-Perez, I., Wijeyesekera, A., Bictash, M., Ebbels, T.M.D., Ueshima, H., Zhao, L., and van Horn, L. (2015). Urinary Metabolic Signatures of Human Adiposity. Sci. Transl. Med., 7.","DOI":"10.1126\/scitranslmed.aaa5680"},{"key":"ref_11","first-page":"65","article-title":"Methodology for the At-Home Collection of Urine Samples for Prostate Cancer Detection","volume":"68","author":"Webb","year":"2020","journal-title":"Bio-techniques"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/pop.2023.0201","article-title":"Patient Perception and Impact of Home Test Kits on Health Care Utilization for Urinary Tract Infection","volume":"27","author":"Billups","year":"2024","journal-title":"Popul. Health Manag."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jclinepi.2009.10.001","article-title":"Opening up the \u201cBlack Box\u201d: Metabolic Phenotyping and Metabolome-Wide Association Studies in Epidemiology","volume":"63","author":"Bictash","year":"2010","journal-title":"J. Clin. Epidemiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kimball, B.A., Wilson, D.A., and Wesson, D.W. (2016). Alterations of the Volatile Metabolome in Mouse Models of Alzheimer\u2019s Disease. Sci. Rep., 6.","DOI":"10.1038\/srep19495"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1194\/jlr.M043232","article-title":"Aberrant Dolichol Chain Lengths as Biomarkers for Retinitis Pigmentosa Caused by Impaired Dolichol Biosynthesis","volume":"54","author":"Wen","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Udo, R., Katsumata, K., Kuwabara, H., Enomoto, M., Ishizaki, T., Sunamura, M., Nagakawa, Y., Soya, R., Sugimoto, M., and Tsuchida, A. (2020). Urinary Charged Metabolite Profiling of Colorectal Cancer Using Capillary Electrophoresis-Mass Spectrometry. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-78038-2"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tarapore, P., Ying, J., Ouyang, B., Burke, B., Bracken, B., and Ho, S.-M. (2014). Exposure to Bisphenol A Correlates with Early-Onset Prostate Cancer and Promotes Centrosome Amplification and Anchorage-Independent Growth in Vitro. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090332"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/14789450.2021.1937133","article-title":"Early Disease Biomarkers Can Be Found Using Animal Models Urine Proteomics","volume":"18","author":"Wei","year":"2021","journal-title":"Expert. Rev. Proteom."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Li, X., and Yang, L. (2022). Urinary Exosomes: Emerging Therapy Delivery Tools and Biomarkers for Urinary System Diseases. Biomed. Pharmacother., 150.","DOI":"10.1016\/j.biopha.2022.113055"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Erbes, T., Hirschfeld, M., R\u00fccker, G., Jaeger, M., Boas, J., Iborra, S., Mayer, S., Gitsch, G., and Stickeler, E. (2015). Feasibility of Urinary microRNA Detection in Breast Cancer Patients and Its Potential as an Innovative Non-Invasive Biomarker. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1190-4"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Earle, A., Bessonny, M., Benito, J., Huang, K., Parker, H., Tyler, E., Crawford, B., Khan, N., Armstrong, B., and Stamatikos, A. (2022). Urinary Exosomal MicroRNAs as Biomarkers for Obesity-Associated Chronic Kidney Disease. J. Clin. Med., 11.","DOI":"10.3390\/jcm11185271"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhao, M., Meng, Q., and Zhang, M. (2023). Urinary Insulin Signaling Pathway Related Proteins May Serve as Potential Biomarkers for Monitoring Diabetes Mellitus without Hypertension and Hyperlipidemia. Medicine, 102.","DOI":"10.1097\/MD.0000000000032862"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Esfahani, S., Wicaksono, A., Mozdiak, E., Arasaradnam, R.P., and Covington, J.A. (2018). Non-Invasive Diagnosis of Diabetes by Volatile Organic Compounds in Urine Using FAIMS and Fox4000 Electronic Nose. Biosensors, 8.","DOI":"10.3390\/bios8040121"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"F720","DOI":"10.1152\/ajprenal.00507.2019","article-title":"Phosphoenolpyruvate Carboxykinase in Urine Exosomes Reflect Impairment in Renal Gluconeogenesis in Early Insulin Resistance and Diabetes","volume":"318","author":"Sharma","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Takakado, M., Takata, Y., Yamagata, F., Yaguchi, M., Hiasa, G., Sato, S., Funada, J.-I., Kawazu, S., and Osawa, H. (2020). Simple and Non-Invasive Screening Method for Diabetes Based on Myoinositol Levels in Urine Samples Collected at Home. BMJ Open Diabetes Res. Care, 8.","DOI":"10.1136\/bmjdrc-2019-000984"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.diabres.2013.05.004","article-title":"Identification of Urinary Biomarkers for Type 2 Diabetes Using Bead-Based Proteomic Approach","volume":"101","author":"Chu","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41387-024-00310-5","article-title":"Urine Biomarkers in Type 2 Diabetes Mellitus with or without Microvascular Complications","volume":"14","author":"Zhang","year":"2024","journal-title":"Nutr. Diabetes"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Li, X., Zhang, X., Wang, S., Li, Y., Meng, C., Wang, J., Chang, B., and Yang, J. (2024). Simultaneous Detection of Multiple Urinary Biomarkers in Patients with Early-Stage Diabetic Kidney Disease Using Luminex Liquid Suspension Chip Technology. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1443573"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1159\/000489148","article-title":"Urinary and Blood MicroRNA-126 and -770 Are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: A Meta-Analysis","volume":"46","author":"Park","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cca.2019.05.001","article-title":"Study on Urine Metabolic Profiling and Pathogenesis of Hyperlipidemia","volume":"495","author":"Yang","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpha.2014.04.002","article-title":"UPLC-Q-TOF\/MS Based Metabolomic Profiling of Serum and Urine of Hyperlipidemic Rats Induced by High Fat Diet","volume":"4","author":"Wu","year":"2014","journal-title":"J. Pharm. Anal."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Miao, H., Chen, H., Zhang, X., Yin, L., Chen, D.-Q., Cheng, X.-L., Bai, X., and Wei, F. (2014). Urinary Metabolomics on the Biochemical Profiles in Diet-Induced Hyperlipidemia Rat Using Ultraperformance Liquid Chromatography Coupled with Quadrupole Time-of-Flight SYNAPT High-Definition Mass Spectrometry. J. Anal. Methods Chem., 2014.","DOI":"10.1155\/2014\/184162"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00216-012-5923-9","article-title":"A Combination of Metabolomics and Metallomics Studies of Urine and Serum from Hypercholesterolaemic Rats after Berberine Injection","volume":"403","author":"Liu","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Guo, L., Zhao, P., Xue, S., and Zhu, Z. (2024). Association of Urinary Bisphenol A with Hyperlipidemia and All-Cause Mortality: NHANES 2003\u20132016. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0304516"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3748\/wjg.v23.i15.2771","article-title":"Urinary Metabolomics Analysis Identifies Key Biomarkers of Different Stages of Nonalcoholic Fatty Liver Disease","volume":"23","author":"Dong","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Liu, C.-H., Zheng, S., Wang, S., Wu, D., Jiang, W., Zeng, Q., Wei, Y., Zhang, Y., and Tang, H. (2022). Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease. Diagnostics, 12.","DOI":"10.3390\/diagnostics12061412"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/apt.15710","article-title":"Accurate Non-Invasive Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease Using the Urinary Steroid Metabolome","volume":"51","author":"Moolla","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Haam, J.-H., Lee, Y.K., Suh, E., and Kim, Y.-S. (2022). Characteristics of Urine Organic Acid Metabolites in Nonalcoholic Fatty Liver Disease Assessed Using Magnetic Resonance Imaging with Elastography in Korean Adults. Diagnostics, 12.","DOI":"10.3390\/diagnostics12051199"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ijo.2015.40","article-title":"Urinary (1)H-NMR-Based Metabolic Profiling of Children with NAFLD Undergoing VSL#3 Treatment","volume":"39","author":"Miccheli","year":"2015","journal-title":"Int. J. Obes."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ohashi, Y., Ooyama, H., Makinoshima, H., Takada, T., Matsuo, H., and Ichida, K. (2024). Plasma and Urinary Metabolomic Analysis of Gout and Asymptomatic Hyperuricemia and Profiling of Potential Biomarkers: A Pilot Study. Biomedicines, 12.","DOI":"10.3390\/biomedicines12020300"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1021\/acsomega.0c06229","article-title":"Urinary Proteomic Characteristics of Hyperuricemia and Their Possible Links with the Occurrence of Its Concomitant Diseases","volume":"6","author":"Huo","year":"2021","journal-title":"ACS Omega"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Al Ashmar, S., Anwardeen, N.R., Anlar, G.G., Pedersen, S., Elrayess, M.A., and Zeidan, A. (2024). Metabolomic Profiling Reveals Key Metabolites Associated with Hypertension Progression. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1284114"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.trsl.2016.07.003","article-title":"Hypertensive Patients Exhibit an Altered Metabolism. A Specific Metabolite Signature in Urine Is Able to Predict Albuminuria Progression","volume":"178","author":"Segura","year":"2016","journal-title":"Transl. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e511","DOI":"10.1097\/MD.0000000000000511","article-title":"Urinary Albumin as a Marker of Future Blood Pressure and Hypertension in the General Population","volume":"94","author":"Takase","year":"2015","journal-title":"Medicine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/HYPERTENSIONAHA.123.21084","article-title":"Associations of Urine Biomarkers of Kidney Tubule Health with Incident Hypertension and Longitudinal Blood Pressure Change in Middle-Aged Adults: The CARDIA Study","volume":"80","author":"Khan","year":"2023","journal-title":"Hypertension"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ju, W., Nair, V., Smith, S., Zhu, L., Shedden, K., Song, P.X.K., Mariani, L.H., Eichinger, F.H., Berthier, C.C., and Randolph, A. (2015). Tissue Transcriptome-Driven Identification of Epidermal Growth Factor as a Chronic Kidney Disease Biomarker. Sci. Transl. Med., 7.","DOI":"10.1126\/scitranslmed.aac7071"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1007\/s11356-021-17091-4","article-title":"The Association between Urinary Metabolites of Polycyclic Aromatic Hydrocarbons (PAHs) and Cardiovascular Diseases and Blood Pressure: A Systematic Review and Meta-Analysis of Observational Studies","volume":"29","author":"Mirzababaei","year":"2022","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4103\/0366-6999.229899","article-title":"Identification of Potential Biomarkers for Urine Metabolomics of Polycystic Ovary Syndrome Based on Gas Chromatography-Mass Spectrometry","volume":"131","author":"Zou","year":"2018","journal-title":"Chin. Med. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2015.06.008","article-title":"Detection of Urine Metabolites in Polycystic Ovary Syndrome by UPLC Triple-TOF-MS","volume":"448","author":"Wang","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Fulghesu, A.M., Piras, C., Dess\u00ec, A., Succu, C., Atzori, L., Pintus, R., Gentile, C., Angioni, S., and Fanos, V. (2021). Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS). Metabolites, 11.","DOI":"10.3390\/metabo11070437"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11306-020-1642-y","article-title":"Serum Metabolomics Reveals Metabolic Profiling for Women with Hyperandrogenism and Insulin Resistance in Polycystic Ovary Syndrome","volume":"16","author":"Zhang","year":"2020","journal-title":"Metabolomics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1515\/cclm-2021-0598","article-title":"Urine Organic Acids May Be Useful Biomarkers for Metabolic Syndrome and Its Components in Korean Adults","volume":"59","author":"Haam","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12933-021-01349-9","article-title":"A Molecular Signature for the Metabolic Syndrome by Urine Metabolomics","volume":"20","author":"Bruzzone","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s43586-022-00175-x","article-title":"Liquid Chromatography-Tandem Mass Spectrometry for Clinical Diagnostics","volume":"2","author":"Thomas","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2215\/CJN.07420619","article-title":"Proteomics and Metabolomics in Kidney Disease, Including Insights into Etiology, Treatment, and Prevention","volume":"15","author":"Dubin","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1017\/S0007114513002602","article-title":"Impact of geographical region on urinary metabolomic and plasma fatty acid profiles in subjects with the metabolic syndrome across Europe: The LIPGENE study","volume":"111","author":"Walsh","year":"2014","journal-title":"Br. J. Nutr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11306-010-0234-7","article-title":"Standardization of Factors That Influence Human Urine Metabolomics","volume":"7","author":"Rasmussen","year":"2011","journal-title":"Metabolomics"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Nicholson, G., Rantalainen, M., Maher, A.D., Li, J.V., Malmodin, D., Ahmadi, K.R., Faber, J.H., Hallgr\u00edmsd\u00f3ttir, I.B., Barrett, A., and Toft, H. (2011). Human Metabolic Profiles Are Stably Controlled by Genetic and Environmental Variation. Mol. Syst. Biol., 7.","DOI":"10.1038\/msb.2011.57"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1021\/ac0708588","article-title":"Investigations of the Effects of Gender, Diurnal Variation, and Age in Human Urinary Metabolomic Profiles","volume":"79","author":"Slupsky","year":"2007","journal-title":"Anal. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Liu, X., Tian, X., Qinghong, S., Sun, H., Jing, L., Tang, X., Guo, Z., Liu, Y., Wang, Y., and Ma, J. (2022). Characterization of LC-MS Based Urine Metabolomics in Healthy Children and Adults. PeerJ, 10.","DOI":"10.7717\/peerj.13545"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/5\/633\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:23:38Z","timestamp":1760030618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/5\/633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["biom15050633"],"URL":"https:\/\/doi.org\/10.3390\/biom15050633","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]}}}